Zilretta 32 MG vials
Ended Awarded Last action
- Contract number
- SPE2DR26F1AG9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,225
Award facts
- Contract value 100% obligated
- $2,225.16 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On January 21, 2026, the Defense Logistics Agency awarded a $2,225.16 delivery order to AmerisourceBergen Drug Corp for Zilretta 32 mg vials, with a completion date of February 11, 2026. This competitive award, issued under firm fixed-price terms with no set-aside designation, represents a child delivery order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical. The underlying IDC, valued at $999,999,999.00 and running through December 2026, serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters.
Zilretta is a corticosteroid injection used for intra-articular administration to manage osteoarthritis pain, representing one of many specialty pharmaceutical products delivered through AmerisourceBergen's federal medical supply contracts. The company's extensive portfolio with the Defense Logistics Agency demonstrates its capability to fulfill critical medical procurement requirements across multiple therapeutic domains, serving defense health organizations including the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. This delivery order reflects the company's ongoing role as a key pharmaceutical distributor supporting military medical readiness and treatment facility operations.
Quick answers
Who was awarded contract SPE2DR26F1AG9?
SPE2DR26F1AG9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 21, 2026.
How much is contract SPE2DR26F1AG9 worth?
The government has obligated $2,225 on SPE2DR26F1AG9.
Is contract SPE2DR26F1AG9 an order under another contract?
Yes. SPE2DR26F1AG9 is a delivery order under SPE2DR25D1205, an indefinite delivery contract.
Was contract SPE2DR26F1AG9 competed?
The extent of competition for SPE2DR26F1AG9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award